ClinicalTrials.gov
ClinicalTrials.gov Menu

To Evaluate the Blood Levels and Safety of IV and Subcutaneous CDP6038 in Subjects With Rheumatoid Arthritis Using Methotrexate

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01009242
Recruitment Status : Completed
First Posted : November 6, 2009
Last Update Posted : August 27, 2014
Sponsor:
Information provided by (Responsible Party):
UCB Pharma

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : September 2010
  Actual Study Completion Date : September 2010
  Certification/Extension First Submitted : October 3, 2011